Judit Jørgensen

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real‐world patients”.

Minimal relapse risk and early normalization of survival for patients with Burkitt lymphoma treated with intensive immunochemotherapy: an international study of 264 real‐world patients

British Journal of Haematology(2020)10.1111/bjh.16425

N/A

0DataRank · unranked

23 citations

Fredrik Ellin, Knut B. Smeland, Tove Wästerlid, Jacob Haaber Christensen, Judit Jørgensen +19 more

Relapsed/Refractory International Prognostic Index (R/R‐IPI): An international prognostic calculator for relapsed/refractory diffuse large B‐cell lymphoma

American Journal of Hematology(2021)10.1002/ajh.26149

N/A

0DataRank · unranked

22 citations

Lasse Hjort Jakobsen, Raphael Mwangi, Norbert Schmitz, Umar Farooq, C. R. Flowers +18 more